Corrective gene transfer in the human skin disorder lamellar ichthyosis - PubMed (original) (raw)

Corrective gene transfer in the human skin disorder lamellar ichthyosis

K A Choate et al. Nat Med. 1996 Nov.

Abstract

Lamellar ichthyosis (LI) is a disfiguring skin disease characterized by abnormal epidermal differentiation and defective cutaneous barrier function. LI has been associated with loss of keratinocyte transglutaminase 1 (TGase1), an enzyme believed necessary for normal formation of the cornified epidermal barrier. Using LI as a prototype for therapeutic cutaneous gene delivery, we have used the human skin/immunodeficient mouse xenograft model to correct the molecular, histologic and functional abnormalities of LI patient skin in vivo. We have used TGase1-deficient primary keratinocytes from LI patients combined with high-efficiency transfer of functional TGase1 to regenerate engineered human LI epidermis on immunodeficient mice. Engineered LI epidermis displayed normal TGase1 expression in vivo, unlike unengineered LI epidermis where TGase1 was absent. Epidermal architecture was also normalized by TGase1 restoration, as was expression of the epidermal differentiation marker filaggrin. Engineered LI skin demonstrated restoration of cutaneous barrier function measures to levels seen in epidermis regenerated by keratinocytes from patients with normal skin, indicating functional correction in vivo of the proposed primary pathophysiologic defect in LI. These results confirm a major role for TGase1 in epidermal differentiation and demonstrate a potential future approach to therapeutic gene delivery in human skin.

PubMed Disclaimer

Cited by

Identifying a hyperkeratosis signature in autosomal recessive congenital ichthyosis: Mdm2 inhibition prevents hyperkeratosis in a rat ARCI model.
Youssef G, Ono M, Brown SJ, Kinsler VA, Sebire NJ, Harper JI, O'Shaughnessy RFL. Youssef G, et al. J Invest Dermatol. 2014 Mar;134(3):858-861. doi: 10.1038/jid.2013.374. Epub 2013 Sep 4. J Invest Dermatol. 2014. PMID: 24005053 No abstract available.
Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
Kwong A, Cogan J, Hou Y, Antaya R, Hao M, Kim G, Lincoln V, Chen Q, Woodley DT, Chen M. Kwong A, et al. Mol Ther. 2020 May 6;28(5):1327-1338. doi: 10.1016/j.ymthe.2020.03.006. Epub 2020 Mar 17. Mol Ther. 2020. PMID: 32222156 Free PMC article. Clinical Trial.
Topical enzyme-replacement therapy restores transglutaminase 1 activity and corrects architecture of transglutaminase-1-deficient skin grafts.
Aufenvenne K, Larcher F, Hausser I, Duarte B, Oji V, Nikolenko H, Del Rio M, Dathe M, Traupe H. Aufenvenne K, et al. Am J Hum Genet. 2013 Oct 3;93(4):620-30. doi: 10.1016/j.ajhg.2013.08.003. Epub 2013 Sep 19. Am J Hum Genet. 2013. PMID: 24055110 Free PMC article.
Inability of keratinocytes lacking their specific transglutaminase to form cross-linked envelopes: absence of envelopes as a simple diagnostic test for lamellar ichthyosis.
Jeon S, Djian P, Green H. Jeon S, et al. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):687-90. doi: 10.1073/pnas.95.2.687. Proc Natl Acad Sci U S A. 1998. PMID: 9435253 Free PMC article.
Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy.
Ghazizadeh S, Carroll JM, Taichman LB. Ghazizadeh S, et al. J Virol. 1997 Dec;71(12):9163-9. doi: 10.1128/JVI.71.12.9163-9169.1997. J Virol. 1997. PMID: 9371574 Free PMC article.

Corrective gene transfer in the human skin disorder lamellar ichthyosis - PubMed (original) (raw)